Pure Global

Clinical Evaluation of Biomedics Monthly Sphere and Avaira Vitality Sphere - Trial NCT06400914

Access comprehensive clinical trial information for NCT06400914 through Pure Global AI's free database. This phase not specified trial is sponsored by Coopervision, Inc. and is currently Recruitment Completed. The study focuses on Ametropia. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06400914
Recruitment Completed
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06400914
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Clinical Evaluation of Biomedics Monthly Sphere and Avaira Vitality Sphere

Study Focus

Ametropia

Lens A (ocufilcon D)

Interventional

device

Sponsor & Location

Coopervision, Inc.

Mexico City, Mexico

Timeline & Enrollment

N/A

Apr 02, 2024

May 06, 2024

40 participants

Primary Outcome

Lens Fit Acceptance Ratings

Summary

The aim of this study is to compare the short-term clinical performance of two sphere contact
 lenses.

ICD-10 Classifications

Amblyopia ex anopsia
Amoebiasis
Amoebiasis, unspecified
Myoclonus
Oesophagitis

Data Source

ClinicalTrials.gov

NCT06400914

Device Trial